DNTH,Dianthus Therapeutics, Inc. | Healthcare

Healthcare

DNTH

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Dianthus Therapeutics, Inc.DNTH

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases.

It develops DNTH103 that is in phase 1 clinical trails in patients with generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy.

Dianthus Therapeutics, Inc. was incorporated in 2015 and is based in New York, New York.

Latest News >

Why TransCode Therapeutics (RNAZ) Stock Is Getting Hammered

May 13, 2024

TransCode Therapeutics Inc ( RNAZ ) shares are trading lower by 40.6% to $0.84 during Monday’s session after the company disclosed plans for a potential reverse stock split in an open letter to its shareholders. The proposal arises from the company’s failure to meet the Minimum Bid Requirement, as its common stock did not close at $1.00 or more for...

RingCentral, Avaya Expand Partnership to Enhance Customers' Communications, Collaboration Experiences

May 13, 2024

11:26 AM EDT, 05/13/2024 (MT Newswires) -- RingCentral ( RNG ) and Avaya have expanded their partnership to improve communications and collaboration experiences for Avaya's customers, the companies said Monday. The partnership provides a new hybrid offering that allows customers to combine current Avaya investments with enhanced collaboration capabilities from RingCentral ( RNG ) for a seamless user experience across...

Why Is Health Care Company Fortrea Stock Diving Today?

May 13, 2024

Fortrea Holdings Inc. ( FTRE ) shares are trading lower after the company reported soft first-quarter FY24 results and cut its revenue outlook. Revenue of $662.1 million missed the consensus of $754.6 million. As of March-end, the backlog stood at $7.4 billion, and the book-to-bill ratio for the quarter was 1.11x. Adjusted EBITDA stood at $29.5 million, a decline from $41.7 million a...

Supplier Prices Threaten To Impact Inflation Over Turbulent Commodity Markets, Middle East Instability

May 13, 2024

This week, traders are gearing up for significant market volatility centered around two major inflation reports: the Producer Price Index (PPI) on Tuesday and the Consumer Price Index (CPI) on Wednesday. These reports are crucial indicators of inflationary trends in the U.S. economy and could heavily influence the Federal Reserve’s monetary policy decisions in the coming months. What to Expect...